Physician

David M Fortenberry, M.D.

According to 2025 Medicare claims, David Fortenberry, M.D. (NPI: 1215090774) practices general surgery in the Dothan, AL market, with the plurality of this provider's patient population coming from Houston, AL. This provider's primary affiliated billing organization is CENTER FOR VEIN RESTORATION AL LLC (NPI: 1164897427; TIN: 810759730) and primary practice location at 36303-3040.

Fortenberry's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 201 traditional Medicare patients, billed 823 HCPCS/CPT codes, and received $423,382 in Medicare payments. The top billing code was 36465 (Injection of chemical agent into single incompetent vein of leg using ultrasound guidance). Part D data shows 36 prescription claims across 11 beneficiaries totaling $20,463 in drug costs, led by Xarelto (Rivaroxaban). Open Payments data shows 8 records totaling $152. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $46,834 and ending at $423,382. Concurrently, Part D prescription costs have risen steadily, from $1,020 to $20,463. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$233K$467K2015 Medicare payment: $46,834 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $51,254 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $63,981 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $49,005 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $466,692 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $69,331 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $135,925 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $29,276 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $213,890 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $423,382 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015283596$46,834
2016262504$51,254
2017265572$63,981
2018235470$49,005
20191151,067$466,692
202031167$69,331
202162391$135,925
202241125$29,276
2023139443$213,890
2024201823$423,382

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$10K$20K2015 Drug cost: $1,020 (USD; Tot_Drug_Cst)2016 Drug cost: $1,410 (USD; Tot_Drug_Cst)2017 Drug cost: $1,406 (USD; Tot_Drug_Cst)2018 Drug cost: $2,255 (USD; Tot_Drug_Cst)2019 Drug cost: $9,720 (USD; Tot_Drug_Cst)2020 Drug cost: $4,720 (USD; Tot_Drug_Cst)2021 Drug cost: $5,309 (USD; Tot_Drug_Cst)2022 Drug cost: $1,424 (USD; Tot_Drug_Cst)2023 Drug cost: $4,183 (USD; Tot_Drug_Cst)2024 Drug cost: $20,463 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153880$1,020
20162750$1,410
20172771$1,406
20182866$2,255
20191642$9,720
20201222$4,720
20211832$5,309
20221319$1,424
2023N/R16$4,183
20241136$20,463

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
36465Injection of chemical agent into single incompetent vein of leg using ultrasound guidance105249$897
36475Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance87157$748
36470Injection of chemical agent into single incompetent vein3559$82
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3740$77
76942Ultrasonic guidance for needle placement45100$42

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XareltoRivaroxaban20702$13,839
EliquisApixaban11330$6,579

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$152Nevro Corp.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David M. Fortenberry, M.D.?

Tedicare shows public-source Medicare data for David M. Fortenberry, M.D. (NPI 1215090774), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David M. Fortenberry, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David M. Fortenberry, M.D.?

David M. Fortenberry, M.D. is linked to CENTER FOR VEIN RESTORATION AL LLC (billing NPI 1164897427) in the available physician profile data.

Does David M. Fortenberry, M.D. have Open Payments data?

David M. Fortenberry, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.